Abstract:
Introduction: Each year Cardiovascular Diseases (CVD) are causing over 4 mln deaths in
Europe, 47% from total deaths. The high level of deaths caused by vascular pathology and the deficit of autografts, because of comorbidities and other causes, and deficit of synthetic grafts with small lumen
(ID<6mm) as well, creates objectives for using tissue engineering in obtaining compatible alo-xenogenic
vessels, after decellularization-recellularization principle. Aim: determining an optimal method of blood
vessel decellularization by maximal preservation of it’s biological proprieties.
Material and methods: Study object – human umbilical artery (n = 24; 18 – being
decellularized, 6 – control lot). The decellularization was done by following methods: enzymatic –
0.25% Tripsin solution; chemical – 1% SDS solution, combined method – 0.25% Tripsin solution + 1%
SDS sol. The decellularization efficiency was established through microscopical study of the histological
slides.
Results: After decellularization pure matrix was obtained just through combined and chemical
method (using SDS sol.), partial decellularization - through enzymatic method (using Tripsin sol 0.25%),
being proved histologically. The results for vessel stretch test: 1,8±0.03N – combined method;
1,53±0.02N – enzymatic method; 1,83±0,11N – chemical method and 2,33±0,22N for intact vessels. In
swelling test all the vessels resisted to maximal pressure, that was possible to obtain by our device – 280
mmHg.
Conclusion: The most effective decellularization was obtained through combined and chemical
method. Analyzing the strech and swelling test results, we can deduct that the vessels obtained through
these 2 methods can be used as biological grafts.
Description:
Laboratory of Tissue Engineering and Cells Culture, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016